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Astroglial cells possess an array of cellular defense systems, including superoxide dismu-
tase (SOD) and catalase antioxidant enzymes, to prevent damage caused by oxidative
stress on the central nervous system. Astrocytes speciﬁcally synthesize and release
endozepines, a family of regulatory peptides including the octadecaneuropeptide (ODN).
ODN is the ligand of both central-type benzodiazepine receptors (CBR), and an adenylyl
cyclase- and phospholipase C-coupled receptor. We have recently shown that ODN is a
potent protective agent that prevents hydrogen peroxide (H2O2)-induced inhibition of SOD
and catalase activities and stimulation of cell apoptosis in astrocytes. The purpose of the
present study was to investigate the type of receptor involved in ODN-induced inhibition of
SOD and catalase in cultured rat astrocytes.We found that ODN induced a rapid stimulation
of SOD and catalase gene transcription in a concentration-dependent manner. In addition,
0.1 nM ODN blocked H2O2-evoked reduction of both mRNA levels and activities of SOD
and catalase. Furthermore, the inhibitory actions of ODN on the deleterious effects of
H2O2 on SOD and catalase were abrogated by the metabotropic ODN receptor antagonist
cyclo1 8[Dleu5]OP, but not by the CBR antagonist ﬂumazenil. Finally, the protective action−
of ODN against H2O2-evoked inhibition of endogenous antioxidant systems in astrocytes
was protein kinase A (PKA)-dependent, but protein kinase C-independent. Taken together,
these data demonstrate for the ﬁrst time that ODN, acting through its metabotropic recep-
tor coupled to the PKA pathway, prevents oxidative stress-induced alteration of antioxidant
enzyme expression and activities. The peptide ODN is thus a potential candidate for the
development of speciﬁc agonists that would selectively mimic its protective activity.
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INTRODUCTION
The octadecaneuropeptide (ODN) is a peptide generated through
the proteolytic cleavage of the 86-amino acid precursor diazepam-
binding inhibitor (DBI; Guidotti et al., 1983) which is exclusively
expressed in astroglial cells in the central nervous system (CNS)
of mammals (Malagon et al., 1993; Burgi et al., 1999; Tonon et al.,
2006). DBI and its derived peptides are collectively designated
by the term endozepines (Tonon et al., 2006). It was initially
reported that ODN acts as an inverse agonist of central-type
benzodiazepine receptors (CBR) that are intrinsic components
of the GABAA receptor-chloride channel complex (Ferrero et al.,
Abbreviations: AC, adenylyl cyclase; CBR, central-type benzodiazepine recep-
tors; CREB, cAMP-responsive element-binding protein; DBI, diazepam-binding
inhibitor; GADPH, glyceraldehyde-3-phosphate dehydrogenase; H2O2, hydrogen
peroxide; ODN, octadecaneuropeptide; PBS, phosphate buffered saline; PKA, pro-
tein kinase A; PKC, protein kinase C; PLC, phospholipase C; ROS, reactive oxygen
species; SOD, superoxide dismutase.
1986). It has been subsequently shown that ODN can also acti-
vate a Gi/0 protein-coupled receptor leading to the activation of
phospholipase C (PLC) in astrocytes (Patte et al., 1995; Leprince
et al., 2001). In addition, recent data indicate that the ODN G
protein-coupled receptor can also activate adenylyl cyclase (AC;
Hamdi et al., 2012). ODN exerts a wide range of biological activ-
ities which are mediated either through CBR, i.e., increase of
aggressiveness and anxiety (Kavaliers and Hirst, 1986; De Mateos-
Verchere et al., 1998), reduction of pentobarbital-induced sleeping
time and drinking (Dong et al., 1999; Manabe et al., 2001), or
through a metabotropic receptor, i.e., inhibition of food intake
(Do Rego et al., 2007). Similarly, at the cellular level, the diverse
effects of ODN are mediated either through CBR, i.e., stimulation
of glial cell and neuroblast proliferation (Gandolfo et al., 1999;
Alfonso et al., 2012) and activation of neurosteroid biosynthe-
sis (Do Rego et al., 2001), or through a metabotropic receptor,
i.e., increase of intracellular calcium concentration in astrocytes
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(Leprince et al., 2001) andmodulationof neuropeptide expression
in neurons (Compère et al., 2003, 2004).
Oxidative stress, resulting from excessive production of reactive
oxygen species (ROS), such as hydrogen peroxide (H2O2), is impli-
cated in the pathology of several neurological disorders including
cerebral ischemia and neurodegenerative diseases (Garcia et al.,
2012; Hayashi et al., 2012). An excess of H2O2 induces imbal-
ance in ROS generation, impairs cellular antioxidant defences and
ﬁnally triggers cell death by apoptosis (Emerit et al., 2004; Shibata
and Kobayashi, 2008). It is well known that astroglial cells con-
tain high levels of ROS scavenger molecules such as glutathione
(Dringen et al., 1999) and the antioxidant enzymes Mn- and
Cu,Zn-superoxide dismutases (Mn- and Cu,Zn-SOD), catalase
and glutathione peroxidase (Lindenau et al., 2000; Sokolova et al.,
2001; Saha and Pahan, 2007). Nonetheless, astroglial cells can
be affected, in terms of viability and functionality, by an insur-
mountable oxidative stress (Ferrero-Gutierrez et al., 2008; Park
et al., 2009). In particular, it has been shown that inhibitionof SOD
and/or catalase activities in cultured astrocytes is associated with
an exacerbation of oxidative damages induced byH2O2 or hypoxia
(Desagher et al., 1996; Bi et al., 2008; Li et al., 2008). Recipro-
cally, cultured astrocytes derived fromCu,Zn-SOD-overexpressing
transgenic mice exhibit increased resistance to oxidative stress
(Chen et al., 2001; Wang et al., 2005). However, little is known
regarding the endogenous factors that modulate glial antioxi-
dant systems. In this context, we have previously reported that,
in cultured astrocytes, ODN exerts a potent protective effect
against oxidative stress-induced apoptosis, and attenuates H2O2-
evoked inhibition of SOD and catalase activities (Hamdi et al.,
2011). More recently, we have shown that the anti-apoptotic activ-
ity of ODN is mediated through the metabotropic endozepine
receptor (Hamdi et al., 2012). In contrast, regarding the effects
of ODN on endogenous antioxidant systems, the receptor and
the signaling mechanism are currently unknown. The purpose
of the present study was thus to examine the effects of ODN
on SOD and catalase gene expression and to determine the
type of receptor involved in the antioxidant action of ODN on
astroglial cells.
MATERIALS AND METHODS
ANIMALS
All experimentswere performed in accordancewithAmericanVet-
erinary Medical Association. Approval for these experiments was
obtained from the Medical Ethical Committee for the Care and
Use of Laboratory Animals of Pasteur Institute of Tunis (approval
number: FST/LNFP/Pro 152012).
REAGENTS
Dulbecco’s modiﬁed Eagle’s medium (DMEM), F12 culture me-
dium, D(+)-glucose, L-glutamine, N-2-hydroxyethylpiperazine-
N-2-ethane sulfonic acid (HEPES), fetal bovine serum (FBS), the
antibiotic-antimycotic solution, and trypsin-EDTA were obtained
from Gibco (Invitrogen, Grand Island NY, USA). Bovine liver
catalase, chelerythrine, DL-epinephrine, H89, Triton X-100, and
insulin were purchased from Sigma Aldrich (St. Louis, MO,USA).
Flumazenil was a generous gift from Hoffmann-La Roche (Basel,
Switzerland). RatODNand theG protein-coupled receptor antag-
onist cyclo1−8[DLeu5]OP were synthesized by using the standard
Fmoc procedure, as previously described (Leprince et al., 2001).
All other reagents were of A grade purity.
SECONDARY CULTURES OF RAT CORTICAL ASTROCYTES
Secondary cultures of rat cortical astrocytes were prepared as pre-
viously described (Castel et al., 2006). Brieﬂy, cerebral hemispheres
from newborn Wistar rats were collected in DMEM/F12 (2:1; v/v)
culture medium supplemented with 2 mM glutamine, 1% insulin,
5 mM HEPES, 0.4% glucose, and 1% of the antibiotic-antimycotic
solution. Dissociated cells were resuspended in culture medium
supplemented with 10% FBS, plated in 175-cm2 ﬂasks (Greiner
Bio-oneGmbH,Frickenhausen,Germany), and incubated at 37◦C
in a 5% CO2/95% O2 atmosphere. When cultures were conﬂuent,
astrocytes were isolated by shaking overnight the ﬂasks with an
orbital agitator and plated on 35-mm Petri dishes at a density
of 0.3 × 106 cells/ml. All experiments were performed on 5- to
7-day-old secondary cultures.
QUANTITATIVE RT-PCR ANALYSIS
Cultured cells were incubated at 37◦C with fresh serum-free
medium. At the end of the incubation, the culture medium was
removed and the cells were washed twice with phosphate buffered
saline (PBS; 0.1 M, pH 7.4). Total RNA was extracted by using Tri
reagent (Sigma, St Quentin Fallavier, France) and puriﬁed using
the NucleoSpin kit (Macherey-Nagel, Hoerd, France). cDNA was
synthetized from 3–4 μg of total RNA with ImProm II Promega
kit (Promega). Quantitative RT-PCR was performed on cDNA in
the presence of a 1× Fast SYBR Green universal PCR Master mix
(Applied Biosystems, Courtaboeuf, France) containing concentra-
tions of dNTPs, MgCl2, SYBR green reporter dye, AmpliTaq Gold
DNA polymerase, and forward (5′-CCTTCTTGTTCTGCAACC-
TGCTA-3′) and reverse (5′-CCGGACTCTCCGGTATCTGA-3′)
SOD (GenBank accession no. NM_012880) primers, or forward
(5′-CCACAGTCGCTGGAGAGTCA-3′) and reverse (5′-GTTTC-
CCACAAGGTCCCAGTT-3′) catalase (GenBank accession no.
NM_012520) primers, or forward (5′-CAGCCTCGTCTCATAGA-
CAAGATG-3′) and reverse (5′- CAATGTCCACTTTGTCACAAG-
AGAA-3′) glyceraldehyde-3-phosphate dehydrogenase (GADPH,
GenBank accession no. NM_017008) primers (300 nM, each; Pro-
ligo, Paris, France), using the ABI Prism 7000 sequence detection
system (Applied Biosystems). The amount of SOD and catalase
cDNA in each sample was calculated by the comparative threshold
cycle (Ct) method and expressed as 2−ΔΔCt using GADPH as an
internal control.
MEASUREMENT OF ANTIOXIDANT ENZYME ACTIVITIES
Cultured cells were incubated at 37◦C with fresh serum-free
medium. At the end of the incubation, cells were washed twice
with PBS and total cellular proteins were extracted by using the
lysis buffer containing 50 mM Tris–HCl (pH 8.0), 10 mM EDTA,
100μMphenylmethylsulfonyl ﬂuoride, and 1%TritonX-100. The
homogenate was centrifuged (16,000 g, 4◦C, 20 min) and the cel-
lular extract contained in the supernatant was stored at −20◦C
until enzyme activity determinations.
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The activity of SOD was measured using a spectrophoto-
metric assay, which consists in measuring epinephrine autox-
idation induced by superoxide anion. Samples, prepared as
described above, were incubated for 3 min with a mixture con-
taining bovine catalase (0.4 U/μl), DL-epinephrine (5 mg/ml),
and Na2CO3/NaHCO3 buffer (62.5 mM, pH 10.2). The oxi-
dation of epinephrine was measured at 480 nm with a Bio-
Rad spectrophotometer (Bio-Rad Laboratories, Philadelphia,
PA, USA).
The activity of catalase was determined on the basis of the
decrease of H2O2. Samples, prepared as described above, were
mixed with 30 mM H2O2 in PBS. The disappearance of H2O2 was
measured at 240 nm for 180 s at 30 s intervals. Catalase activ-
ity was calculated using the extinction coefﬁcient of 40/mM/cm
for H2O2.
STATISTICAL ANALYSIS
Data are presented as the mean ± SEM from three independent
experiments performed in quadruplicate. Statistical analysis of the
data was performed by using Student’s t-test, ANOVA, followed
by Bonferroni’s test, and two-way ANOVA test. A p-value of 0.05
or less was considered as statistically signiﬁcant.
RESULTS
ODN INCREASES SOD AND CATALASE mRNA LEVELS IN CULTURED
ASTROCYTES
We have previously shown that picomolar concentrations of ODN
suppress the inhibitory effects of 300 μM H2O2 on SOD and
catalase activities in cultured rat astrocytes (Hamdi et al., 2011).
To explore the mechanism involved in the effect of ODN on
antioxidant enzyme systems we monitored SOD and catalase
gene expression by quantitative PCR. Time-course experiments
revealed thatODN (0.1 nM) signiﬁcantly enhanced SODand cata-
lasemRNA levels within 2minwith amaximumeffect after 10min
and 5 min of incubation, respectively (Figure 1A). Thereafter,
the stimulatory effect of ODN on SOD and catalase expres-
sion gradually declined and vanished 60 and 30 min after the
onset of ODN administration, respectively. Exposure of astro-
cytes to increasing concentrations of ODN (0.01 pM to 0.1 nM)
induced a concentration-dependent increase of SOD and cata-
lase mRNA levels (Figure 1A, inset). In contrast, incubation of
astrocytes with graded concentrations of H2O2 (100–500 μM)
dose-dependently decreased both SOD and catalase mRNA lev-
els (Figure 1B). We next examined the effects of ODN/H2O2
co-incubation on enzyme expression. For moderate concentra-
tions of H2O2 (100–300 μM), ODN (0.1 nM) restored SOD and
catalase mRNA levels above control, whereas for higher con-
centrations of H2O2 (400 and 500 μM), ODN only partially
prevented the decrease of SOD and catalase gene expression
(Figure 1B).
ODN BLOCKS H2O2-EVOKED INHIBITION OF SOD AND CATALASE mRNA
LEVELS AND ACTIVITIES THROUGH ACTIVATION OF A METABOTROPIC
RECEPTOR COUPLED TO THE PKA PATHWAY
We next examined the type of receptor of ODN involved in the
stimulatory effects of ODN on endogenous antioxidant systems.
Administration of the selective metabotropic receptor antagonist
cyclo1−8[DLeu5]OP (1 μM) to cultured astrocytes did not induce
any modiﬁcation of SOD and catalase mRNA levels and activ-
ities, but totally abolished the effects of 0.1 nM ODN on
H2O2-evoked inhibition of antioxidant enzyme gene transcrip-
tion and activities. In contrast, the CBR antagonist ﬂumazenil
(1 μM) did not affect the protective action of ODN against the
deleterious effect of H2O2 on endogenous antioxidant systems
(Figures 2A,B).
Incubation of astrocytes with the selective protein kinase A
(PKA) inhibitor H89 (20 μM) abrogated the effect of ODN on
the inhibitory action of H2O2 on SOD and catalase mRNA levels
and activities. In contrast, administration of the protein kinase C
(PKC) inhibitor chelerythrine (0.1 μM) did not modify the effects
of ODN (Figures 3A,B), indicating that only the PKA pathway is
involved in the protective activity of ODN.
DISCUSSION
Alteration of endogenous antioxidant systems, especially decrease
of SOD and catalase activities, causes exacerbation of oxidative
damages leading to apoptosis in various cell types, includ-
ing astroglial cells (Giffard and Swanson, 2005; Lopez et al.,
2007; Bi et al., 2008). Here, we demonstrate that ODN prevents
the decrease of SOD and catalase mRNA levels and activities
induced by H2O2 in cultured astrocytes, through activation of a
metabotropic receptor positively coupled to theAC/PKA signaling
pathway.
We have previously reported that, in cultured astrocytes, ODN
at very low concentrations (in the picomolar range) stimulates
SOD and catalase activities (Hamdi et al., 2011). The present study
shows that, in the same range of concentrations, ODN induces
a dose-dependent increase of SOD and catalase mRNA levels in
cultured astroglial cells, indicating that ODN regulates not only
enzyme activity but also gene transcription. Although SOD and
catalase genes exhibit hallmarks of typical housekeeping genes,
it has been shown that their promoters encompass consensus
sequences for regulatory elements such as metal-responsive ele-
ment, antioxidant responsive element, glucocorticoid-response
element, and nuclear factor-κB (Nenoi et al., 2001; Zhu et al.,
2001; Zelko et al., 2002), suggesting that these genes are actu-
ally regulated in the CNS. As a matter of fact, SOD and catalase
gene expression is selectively increased by inﬂammatorymediators
such as interleukin-1β, interferon (IFN)-γ, IFN-β, or lipopolysac-
charides in astrocytes (Mokuno et al., 1994; Kiﬂe et al., 1996;
Vergara et al., 2010). Previous data have shown that ODN is specif-
ically produced by astroglial cells (Tonon et al., 1990; Malagon
et al., 1993; Compère et al., 2010) and that its release is reg-
ulated by various factors including agonists of formyl peptide
receptors (Tokay et al., 2008) which are involved in inﬂammation.
These observations suggest that ODN may act as an autocrine
factor to ﬁnely regulate SOD and catalase gene expression in
the brain.
Kinetic experiments indicate that the action of ODNon antiox-
idant enzyme gene transcription is very rapid but transient. Nev-
ertheless, ODN exerts a protective effect against H2O2-reduced
SOD and catalase mRNA levels. Similar time-response curves
have already been observed on SOD and catalase activities, in
cultured astrocytes (Hamdi et al., 2011). These data suggest that
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FIGURE 1 | Protective effects of ODN against H2O2-evoked inhibition of
SOD and catalase mRNA levels in cultured rat astrocytes. (A) Effects of
ODN on SOD and catalase mRNA levels. Astrocytes were incubated in the
absence or presence of ODN (0.1 nM) for the times indicated. Inset, cells
were treated for 10 min with increasing concentrations of ODN (0.01 pM to
0.1 nM). SOD and catalase mRNA levels were measured by quantitative
RT-PCR. Data were corrected using the GAPDH signal as an internal control
and the results are expressed as a percentage of controls. Each value is the
mean (±SEM) of at least four different wells from three independent
experiments. ANOVA followed by the Bonferroni’s test. *p < 0.05;
**p < 0.01; ***p < 0.001; NS, not statistically different vs. control. (B)
Effects of ODN on H2O2-evoked inhibition of SOD and catalase mRNA levels.
Cells were pre-incubated for 10 min in the absence or presence of 0.1 nM
ODN, and then incubated for 1 h with medium alone or with graded
concentrations of H2O2 (100–500 μM) in the absence or presence of ODN.
The results are expressed as a percentage of control. Each value is the mean
(±SEM) of at least four different wells from three independent experiments.
Analyses similar to those in (A) were performed and symbols show the
signiﬁcance vs. H2O2-treated cells: #p < 0.05; ##p < 0.01; ###p < 0.001; ns,
not statistically different.
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FIGURE 2 | Involvement of the G protein-coupled receptor of ODN
in its protective effects against the deleterious action of H2O2 on
SOD and catalase in cultured rat astrocytes. Astrocytes were
pre-incubated for 30 min in the absence or presence of the metabotropic
receptor antagonist cyclo1−8 [Dleu5] OP (1 μM) or the CBR antagonist
ﬂumazenil (1 μM) and then incubated for 1 h with medium alone or with
300 μM H2O2 without or with ODN (0.1 nM). (A) SOD and catalase mRNA
levels were quantiﬁed as described in Figure 1. The results are expressed as a
percentage of control. Each value is the mean (±SEM) of at least three
different wells from three independent experiments. (B)The activity of SOD
was measured using a spectrophotometric assay which consists in
measuring epinephrine autoxidation induced by superoxide anion, and
catalase activity was determined on the basis of the decomposition
of H2O2. The results are expressed as a percentage of SOD or catalase
activity with respect to control. Each value is the mean (±SEM) of at least
four different dishes from three independent experiments. ANOVA followed
by the Bonferroni’s test: [(A, SOD) F = 7.69, df = 40; (A, catalase) F = 8.58,
df = 39; (B, SOD) F = 13.41, df = 44; (B, catalase) F = 7.58, df = 44];
*p < 0.05; ***p < 0.001; NS, not statistically different vs. control.
###p < 0.001; ns, not statistically different vs. H2O2-treated cells. Two-way
ANOVA test: [(A, SOD) F = 5, df = 17; (A, catalase) F = 8.13, df = 17; (B,
SOD) F = 5.87, df = 20; (B, catalase) F = 2.79, df = 19]; §p < 0.05;
§§p < 0.01; Ns, not statistically different vs. ODN + H2O2-cotreated
cells.
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FIGURE 3 | Protein kinase A-dependence of the protective effects of ODN
on the expression and activities of SOD and catalase in cultured rat
astrocytes. Astrocytes were pre-treated for 30 min in the absence or
presence of the PKA inhibitor H89 (20 μM) or the PKC inhibitor chelerythrine
(Chel; 0.1 μM) and then incubated for 1 h with medium alone or with 300 μM
H2O2 without or with ODN (0.1 nM). (A) SOD and catalase mRNA levels
were quantiﬁed as described in Figure 1. The results are expressed as a
percentage of controls. Each value is the mean (±SEM) of at least three
different wells from three independent experiments. (B)The activity of SOD
and catalase were quantiﬁed as described in Figure 2. The results are
expressed as a percentage of SOD or catalase activity with respect to
control. Each value is the mean (±SEM) of at least four different dishes from
three independent experiments. ANOVA followed by the Bonferroni’s test:
[(A, SOD) F = 7.49, df = 65; (A, catalase) F = 5.08, df = 53; (B, SOD)
F = 12.37, df = 55; (B, catalase) F = 9.06, df = 60]; *p < 0.05; ***p < 0.001;
NS, not statistically different vs. control. ###p < 0.001; ns, not statistically
different vs. H2O2-treated cells. Two-way ANOVA test: [(A, SOD) F = 2.40,
df = 20; (A, catalase) F = 2.63, df = 17; (B, SOD) F = 6.97, df = 18; (B,
catalase) F = 4.68, df = 24]; §p < 0.05; §§p < 0.01; Ns, not statistically
different vs. ODN + H2O2-cotreated cells.
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ODN-induced rapid activation of antioxidant systems is required
for the long-lasting inhibition of the deleterious effect of H2O2.
That ODN-induced increase of transcription and activity of
antioxidant enzymes is responsible, at least in part, for inhibi-
tion of cell death is consistent with previous data showing that
SOD and catalase blockers suppress the protective effect of ODN
against H2O2-induced astrocyte apoptosis (Hamdi et al., 2011).
Furthermore, it has been reported that, in cultured astrocytes,
overexpression of SOD is able to prevent ROS-induced alteration
of mitochondrial integrity, caspase-3 activation and thus cells
apoptosis (Yang et al., 2008).
Previous studies have shown that, in cultured astrocytes, ODN
can interact with either CBR associated with the GABAA recep-
tor (Gandolfo et al., 1999) or with a G protein-coupled receptor
positively coupled to PLC (Patte et al., 1995; Leprince et al., 2001).
Here, we found that the inhibitory effects of ODN on H2O2-
evoked reduction of SOD and catalase mRNA levels and activities
were suppressed by the ODN analog cyclo1−8[DLeu5]OP but were
not affected by the speciﬁc CBR antagonist ﬂumazenil. It has
been reported that the cyclic analog of ODN exerts potent antago-
nistic activities on ODN-induced polyphosphoinositide turnover
increase and intracellular calcium mobilization in rat astrocytes
(Leprince et al., 2001). Thus, these data indicate that the antioxi-
dant action of ODN is mediated through the activation of the G
protein-coupled receptor.
We next investigated the signaling cascade involved in the effect
of ODN on endogenous antioxidant systems. ODN blockage of
H2O2-evoked inhibition of SOD and catalase gene transcription
and enzyme activities was totally abrogated by the PKA inhibitor
H89, while the PKC inhibitor chelerythrine had no effect. That,
the ODN G protein-coupled receptor could stimulate the AC/PKA
transduction cascade is in agreement with recent data indicat-
ing that ODN increases the production of cAMP in astrocytes
(Hamdi et al., 2012). Altogether, these observations indicate that
the antioxidant action of ODN against H2O2-induced oxida-
tive stress can be speciﬁcally ascribed to the activation of the
AC/PKA signaling pathway. Consistent with this notion, it has
been shown that the SOD and catalase promoters contain a cAMP-
responsive element-like sequence (Das et al., 1995; Zelko et al.,
2002; Colombo and Moncada, 2009) and that siRNA knock-
down of cAMP-responsive element-binding protein (CREB) or
inhibition of CREB phosphorylation blocks the expression of
SOD in the rat hypothalamus (Hsieh et al., 2008) and the expres-
sion of catalase in human vascular endothelial cells (Colombo
and Moncada, 2009), respectively. The fact that ODN provokes
ERK phosphorylation via a cAMP-dependent pathway in astro-
cytes (Hamdi et al., 2012), strongly suggests that the stimulatory
effect of ODN on SOD and catalase expression can also be
ascribed to activation of the ERK-type MAP kinase transduction
pathway.
The protective effect of ODN against H2O2-reduced antioxi-
dant enzyme expression and activities might have a physiopatho-
logical signiﬁcance in neurodegenerative diseases and stroke. CNS
is sensitive to oxidative stress due to its high metabolic rate and
high levels of unsaturated lipids so that up-regulation of antioxi-
dant enzyme systems in astroglial cells could be beneﬁcial against
cell death observed during and after ischemia and neurodegener-
ative diseases. In agreement with this hypothesis, we have recently
shown that the endozepine ODN exerts a potent protective action
against apoptosis induced by oxidative stress in astrocytes (Hamdi
et al., 2011, 2012) and that the anti-apoptotic effect of ODN is
attributable to activation of the antioxidant enzymes that act as
scavengers of H2O2 and ROS (Hamdi et al., 2011). The fact that
the glioprotective action of ODN is likely mediated through the
metabotropic receptor is of particular interest. Previous data indi-
cate thatODN induces awide range of activities through activation
of CBR (Tonon et al., 2006). In particular, ODN has been initially
described as an anxiogenic peptide (De Mateos-Verchere et al.,
1998). Since cyclic analog of ODN do not recognize CBR (Lep-
rince et al., 2001), the development of speciﬁc cyclic agonists that
would selectively mimic the glioprotective effect of ODN might
prove useful for the treatment of ischemia and neurodegenerative
diseases.
In conclusion, the present study has demonstrated that the
endozepine ODN, acting through a metabotropic receptor sen-
sitive to the cyclo1−8[DLeu5]OP antagonist, exerts a potent
antioxidant action against H2O2-induced oxidative stress in astro-
cytes. This antioxidant effect of ODN is attributable to activation
of both gene expression and activities of enzymatic antioxidant
systems and can be ascribed to the stimulation of the AC/PKA
transduction pathway.
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